B. Ringe

6.4k total citations
145 papers, 4.8k citations indexed

About

B. Ringe is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, B. Ringe has authored 145 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Surgery, 72 papers in Hepatology and 36 papers in Transplantation. Recurrent topics in B. Ringe's work include Organ Transplantation Techniques and Outcomes (92 papers), Liver Disease and Transplantation (51 papers) and Renal Transplantation Outcomes and Treatments (36 papers). B. Ringe is often cited by papers focused on Organ Transplantation Techniques and Outcomes (92 papers), Liver Disease and Transplantation (51 papers) and Renal Transplantation Outcomes and Treatments (36 papers). B. Ringe collaborates with scholars based in Germany, United States and Japan. B. Ringe's co-authors include R. Pichlmayr, Günter Tusch, Arved Weimann, Christian Wittekind, H. Bunzendahl, Michael Oellerich, Karl J. Oldhafer, Wolf O. Bechstein, Christian Wittekind and H. Maschek and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Hepatology.

In The Last Decade

B. Ringe

142 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Ringe Germany 34 3.0k 2.8k 1.3k 942 741 145 4.8k
Aksel Foss Norway 34 2.5k 0.8× 1.2k 0.4× 1.1k 0.9× 654 0.7× 834 1.1× 76 4.3k
J.A.C. Buckels United Kingdom 37 2.1k 0.7× 1.2k 0.4× 780 0.6× 1.6k 1.7× 209 0.3× 110 3.9k
Choon Hyuck David Kwon South Korea 36 3.2k 1.1× 3.1k 1.1× 1.7k 1.3× 631 0.7× 542 0.7× 305 5.3k
Jean-Bernard Otté Belgium 34 2.3k 0.8× 1.8k 0.6× 596 0.5× 629 0.7× 346 0.5× 113 3.5k
Seisuke Sakamoto Japan 36 2.9k 1.0× 2.3k 0.8× 782 0.6× 295 0.3× 342 0.5× 242 4.1k
Bo‐Göran Ericzon Sweden 32 1.6k 0.5× 1.5k 0.5× 1.2k 0.9× 682 0.7× 416 0.6× 139 4.2k
Deborah K. Freese United States 30 2.1k 0.7× 1.4k 0.5× 1.1k 0.9× 396 0.4× 266 0.4× 74 3.3k
Frank Lehner Germany 31 1.0k 0.3× 1.1k 0.4× 666 0.5× 956 1.0× 822 1.1× 129 3.7k
Michihiro Hayashi Japan 30 3.0k 1.0× 3.0k 1.1× 1.0k 0.8× 665 0.7× 284 0.4× 118 4.3k
Yvon Calmus France 29 1.7k 0.6× 1.7k 0.6× 1.1k 0.8× 291 0.3× 980 1.3× 109 3.1k

Countries citing papers authored by B. Ringe

Since Specialization
Citations

This map shows the geographic impact of B. Ringe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Ringe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Ringe more than expected).

Fields of papers citing papers by B. Ringe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Ringe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Ringe. The network helps show where B. Ringe may publish in the future.

Co-authorship network of co-authors of B. Ringe

This figure shows the co-authorship network connecting the top 25 collaborators of B. Ringe. A scholar is included among the top collaborators of B. Ringe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Ringe. B. Ringe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringe, Kristina I., Christian von Falck, Hoen‐oh Shin, et al.. (2012). Evaluation of living liver donors using contrast enhanced multidetector CT – The radiologists impact on donor selection. BMC Medical Imaging. 12(1). 21–21. 9 indexed citations
2.
Ringe, B. & Russell W. Strong. (2008). The Dilemma of Living Liver Donor Death. Transplantation. 85(6). 790–793. 57 indexed citations
3.
Ringe, Kristina I., E Schirg, Michael Melter, et al.. (2007). Der kongenitale portosystemische Shunt. Der Radiologe. 48(5). 493–502. 4 indexed citations
4.
Ringe, B., Ralph J. Petrucci, Humberto E. Soriano, James C. Reynolds, & William C. Meyers. (2007). Death of a living liver donor from illicit drugs. Liver Transplantation. 13(8). 1193–1194. 5 indexed citations
5.
Makuuchi, Masatoshi, Jacques Belghiti, Giulio Belli, et al.. (2003). IHPBA concordant classification of primary liver cancer: working group report. Journal of Hepato-Biliary-Pancreatic Surgery. 10(1). 26–30. 57 indexed citations
6.
Ringe, B., et al.. (2002). Graft rupture after living donor liver transplantation. Transplantation Proceedings. 34(6). 2268–2271. 4 indexed citations
7.
Ringe, B., Felix Braun, Thomas Lorf, et al.. (2001). A NOVEL MANAGEMENT STRATEGY OF STEROID-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION: EFFICACY AND SAFETY OF TACROLIMUS AND MYCOPHENOLATE MOFETIL. Transplantation. 71(4). 508–515. 72 indexed citations
8.
Braun, Felix, et al.. (2000). Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation. Transplantation Proceedings. 32(7). 2539–2542. 7 indexed citations
9.
Weimann, Arved, B. Ringe, J. Klempnauer, et al.. (2000). Critical issues in the diagnosis and treatment of hepatocellular adenoma. HPB. 2(1). 25–32. 2 indexed citations
10.
Oldhafer, Karl J., A. Bornscheuer, Nils R. Frühauf, et al.. (1999). RESCUE HEPATECTOMY FOR INITIAL GRAFT NON-FUNCTION AFTER LIVER TRANSPLANTATION. Transplantation. 67(7). 1024–1028. 32 indexed citations
11.
Kopka, L., J. Rodenwaldt, R. Vosshenrich, et al.. (1999). Hepatic Blood Supply: Comparison of Optimized Dual Phase Contrast-enhanced Three-dimensional MR Angiography and Digital Subtraction Angiography. Radiology. 211(1). 51–58. 72 indexed citations
12.
Schütz, Ekkehard, Maria Shipkova, Victor W. Armstrong, et al.. (1998). Therapeutic Drug Monitoring of Mycophenolic Acid: Comparison of HPLC and Immunoassay Reveals New MPA Metabolites. Transplantation Proceedings. 30(4). 1185–1187. 98 indexed citations
13.
Lorf, Thomas, et al.. (1997). Portal vein replacement by hepatic vein transposition. The American Journal of Surgery. 174(3). 353–354. 5 indexed citations
14.
Schütz, Ekkehard, et al.. (1996). The value of serial determination of MEGX and hyaluronic acid early after orthotopic liver transplantation. European Journal of Clinical Investigation. 26(10). 907–916. 10 indexed citations
15.
Nashan, Björn, Hans J. Schlitt, Guenter Tusch, et al.. (1996). Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation. Hepatology. 23(5). 1105–1111. 90 indexed citations
16.
Kiuchi, Tetsuya, Hans J. Schlitt, Karl J. Oldhafer, et al.. (1995). BACKGROUNDS OF EARLY INTRAGRAFT IMMUNE ACTIVATION AND REJECTION IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 60(1). 49–55. 10 indexed citations
17.
Armstrong, Victor W., Ekkehard Schütz, Marion Helmhold, et al.. (1995). Relationship of apolipoproteins Al, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post‐transplant period. European Journal of Clinical Investigation. 25(7). 485–493. 10 indexed citations
18.
Ringe, B., et al.. (1993). Total Hepatectomy and Liver Transplantation as Two-stage Procedure. Annals of Surgery. 218(1). 3–9. 125 indexed citations
19.
Schlitt, Hans J., Uwe Christians, J. S. Bleck, et al.. (1991). Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunction. Transplant International. 4(1). 38–44. 6 indexed citations
20.
Kemnitz, Josef, et al.. (1989). Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Human Pathology. 20(2). 132–143. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026